Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test BCR ABL1 Kinase Domain Mutation Analysis Test is 14 days.

What are the prerequisites for the test BCR ABL1 Kinase Domain Mutation Analysis Test

  • Patients must have a confirmed diagnosis of chronic myeloid leukemia (CML)
  • Prior to testing, patients must have received treatment with tyrosine kinase inhibitors (TKIs)
  • A blood sample is required for analysis
  • Prior authorization from a healthcare provider is necessary

What are the measure values for the test BCR ABL1 Kinase Domain Mutation Analysis Test

  • Positive (Mutant) Result: Detected
  • Negative (Wild-type) Result: Not Detected
  • Indeterminate Result: Inconclusive

What does this test BCR ABL1 Kinase Domain Mutation Analysis Test identify?

This test identifies mutations in the BCR-ABL1 kinase domain. The BCR-ABL1 gene is commonly associated with chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL). Mutations in the kinase domain of the BCR-ABL1 gene can lead to resistance to tyrosine kinase inhibitors (TKIs) used in the treatment of CML and ALL.

Why is this test BCR ABL1 Kinase Domain Mutation Analysis Test taken?

  • Reason for Test:
    • The BCR ABL1 Kinase Domain Mutation Analysis Test is taken to detect mutations in the BCR ABL1 gene.
    • BCR ABL1 gene mutations are commonly associated with certain types of leukemia, such as chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).
    • Identifying these mutations is important for determining the most appropriate treatment options for patients with leukemia.
    • Monitoring BCR ABL1 gene mutations can also help track disease progression and response to therapy.

No FAQs available.

Customer Google Rating